The molecular bases of Alzheimer's disease and other neurodegenerative disorders RB Maccioni, JP Muñoz, L Barbeito Archives of medical research 32 (5), 367-381, 2001 | 644 | 2001 |
Neuroinflammation as a common feature of neurodegenerative disorders L Guzman-Martinez, RB Maccioni, V Andrade, LP Navarrete, MG Pastor, ... Frontiers in pharmacology 10, 1008, 2019 | 587 | 2019 |
Neuroinflammation in the pathogenesis of Alzheimer’s disease. A rational framework for the search of novel therapeutic approaches I Morales, L Guzmán-Martínez, C Cerda-Troncoso, GA Farías, ... Frontiers in cellular neuroscience 8, 112, 2014 | 579 | 2014 |
Role of microtubule-associated proteins in the control of microtubule assembly RB Maccioni, V Cambiazo Physiological reviews 75 (4), 835-864, 1995 | 558 | 1995 |
Interleukin-6 induces Alzheimer-type phosphorylation of tau protein by deregulating the cdk5/p35 pathway RA Quintanilla, DI Orellana, C González-Billault, RB Maccioni Experimental cell research 295 (1), 245-257, 2004 | 484 | 2004 |
Neuroinflammation: implications for the pathogenesis and molecular diagnosis of Alzheimer's disease LE Rojo, JA Fernández, AA Maccioni, JM Jimenez, RB Maccioni Archives of medical research 39 (1), 1-16, 2008 | 463 | 2008 |
The revitalized tau hypothesis on Alzheimer's disease RB Maccioni, G Farías, I Morales, L Navarrete Archives of medical research 41 (3), 226-231, 2010 | 415 | 2010 |
Insulin resistance and Alzheimer's disease: molecular links & clinical implications KF Neumann, L Rojo, LP Navarrete, G Farías, P Reyes, RB Maccioni Current Alzheimer Research 5 (5), 438-447, 2008 | 335 | 2008 |
Inhibition of tau phosphorylating protein kinase cdk5 prevents β-amyloid-induced neuronal death A Alvarez, R Toro, A Cáceres, RB Maccioni FEBS letters 459 (3), 421-426, 1999 | 322 | 1999 |
Controlled proteolysis of tubulin by subtilisin: localization of the site for MAP2 interaction L Serrano, J Avila, RB Maccioni Biochemistry 23 (20), 4675-4681, 1984 | 316 | 1984 |
Involvement of the carboxyl-terminal domain of tubulin in the regulation of its assembly. L Serrano, J De La Torre, RB Maccioni, J Avila Proceedings of the National Academy of Sciences 81 (19), 5989-5993, 1984 | 311 | 1984 |
The role of neuroimmunomodulation in Alzheimer's disease RB Maccioni, LE Rojo, JA Fernandez, RO Kuljis Annals of the New York Academy of Sciences 1153 (1), 240-246, 2009 | 304 | 2009 |
The protein kinase Cdk5: Structural aspects, roles in neurogenesis and involvement in Alzheimer’s pathology RB Maccioni, C Otth, II Concha, JP Muñoz European Journal of Biochemistry 268 (6), 1518-1527, 2001 | 250 | 2001 |
Evidence for the participation of the neuron-specific CDK5 activator P35 during laminin-enhanced axonal growth G Paglini, G Pigino, P Kunda, G Morfini, R Maccioni, S Quiroga, A Ferreira, ... Journal of Neuroscience 18 (23), 9858-9869, 1998 | 244 | 1998 |
Neuroimmunomodulation in the pathogenesis of Alzheimer’s disease I Morales, G Farías, RB Maccioni Neuroimmunomodulation 17 (3), 202-204, 2010 | 197 | 2010 |
Tau protein binds to pericentromeric DNA: a putative role for nuclear tau in nucleolar organization MK Sjoberg, E Shestakova, Z Mansuroglu, RB Maccioni, E Bonnefoy Journal of cell science 119 (10), 2025-2034, 2006 | 195 | 2006 |
Tau oligomers and fibrils induce activation of microglial cells I Morales, JM Jiménez, M Mancilla, RB Maccioni Journal of Alzheimer's Disease 37 (4), 849-856, 2013 | 177 | 2013 |
A cdk5–p35 stable complex is involved in the β-amyloid-induced deregulation of cdk5 activity in hippocampal neurons A Alvarez, JP Munoz, RB Maccioni Experimental cell research 264 (2), 266-274, 2001 | 174 | 2001 |
AβPP induces cdk5-dependent tau hyperphosphorylation in transgenic mice Tg2576 C Otth, II Concha, T Arendt, J Stieler, R Schliebs, C González-Billault, ... Journal of Alzheimer's Disease 4 (5), 417-430, 2002 | 155 | 2002 |
Selective interaction of lansoprazole and astemizole with tau polymers: potential new clinical use in diagnosis of Alzheimer's disease LE Rojo, J Alzate-Morales, IN Saavedra, P Davies, RB Maccioni Journal of Alzheimer's Disease 19 (2), 573-589, 2010 | 154 | 2010 |